VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

S. 2465 · 115th Congress

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act…

Full title

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018

Law · 115-327 · Dec 18, 2018
Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Became law without a recorded vote. It passed by voice vote or unanimous consent, which don't record how each member voted.

TSR ScottSponsor
6 cosponsors · 5 D, 1 R

1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

  1. Senate Introduced Feb 28, 2018
  2. Senate Passed Oct 11, 2018
  3. House Passed Dec 11, 2018
  4. President To the President Dec 13, 2018
  5. President Signed Dec 18, 2018
  6. Law Dec 18, 2018

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018

What it does: CRS summary · Public Law · Dec 18, 2018

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018

(Sec. 2) This bill amends the Public Health Service Act to authorize the Department of Health and Human Services to award grants to government, educational, and nonprofit entities for the purpose of supporting data collection and public health activities regarding heritable blood disorders, including sickle cell disease.

(Sec. 3) Additionally, the bill reauthorizes through FY2023 and revises the sickle cell disease grant program for federally-qualified health centers, nonprofit hospitals or clinics, and university health centers.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018

Also known as: Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018

Latest action (Dec 18, 2018): Became Public Law No: 115-327.

Policy area: Health · Origin: Senate · Introduced: Feb 28, 2018

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

  1. Senate Introduced Feb 28, 2018
  2. Senate Passed Oct 11, 2018
  3. House Passed Dec 11, 2018
  4. President To the President Dec 13, 2018
  5. President Signed Dec 18, 2018
  6. Law Dec 18, 2018

No recorded floor vote found.